Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)

NCT00968409 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

RADIATION: PET
OTHER: Laboratory Testing
OTHER: Safety Testing
DRUG: F18-FFNP

Sponsor

Washington University School of Medicine